Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spero Therapeutics (SPRO) Tax Rate (2023 - 2024)

Spero Therapeutics (SPRO) has disclosed Tax Rate for 2 consecutive years, with 1.67% as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Tax Rate rose 502333.0% year-over-year to 1.67%, compared with a TTM value of 6.7% through Sep 2025, down 8593.0%, and an annual FY2023 reading of 10.22%, changed N/A over the prior year.
  • Tax Rate was 1.67% for Q3 2024 at Spero Therapeutics, down from 0.75% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.75% in Q4 2023 and bottomed at 5025.0% in Q3 2023.